Tamoxifen (Nolvadex) will be approved to PREVENT breast cancer
October 1998
Tamoxifen (Nolvadex) will be approved to PREVENT breast cancer...in high-risk women. It's already used for treatment.
Tamoxifen reduces the risk of developing breast cancer by almost HALF...in women who are at high risk.
But it can't be used indiscriminately...tamoxifen increases the risk of endometrial cancer and blood clots in women over 50.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote